MedPath

Betametasone as postoperative pain treatment for knee arthroscopies at a day surgical center

Conditions
nspecified knee pain investigated by an arthroscopy
Registration Number
EUCTR2009-014717-27-SE
Lead Sponsor
Karolinska Institutet/Södersjukhuset
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
203
Inclusion Criteria

Patients going through knee surgery in a day surgical setting
Patients should be classified either as ASA I or II to be eligible (ASA=American Society of Anesthesiologists)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients going through repair of ligaments will be excluded
Patients unable to understand the protocol
Patients with diabetes
Patients with coagulopathies
Patients with atrial arryhtmias
Patients < 18 years of age
Patients on coticosteroids or NSAIDS two days ahead of surgery
Patients who are pregnant

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To investigate whether the addendum of betametason preoperatively will lower the perception of pain according to a verbal scale after knee surgery in a day surgical setting.<br>Betametason is commonly given as an antiemetic. There is some evidence that betametason could have some impact on the level of postoperative pain.;Secondary Objective: To investigate whether the addendum of betametason preoperatively will lower the perception of pain according to a verbal and a visual analogue scale (VAS) after knee surgery in a day surgical setting.<br>;Primary end point(s): To investigate whether the addendum of betametason preoperatively will lower the perception of pain according to a verbal scale after knee surgery in a day surgical setting.<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath